Yousef GM - Search Results

1

Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer.

Kolin DL, Sy K, Rotondo F, Bassily MN, Kovacs K, Brezden-Masley C, Streutker CJ, Yousef GM. Kolin DL, et al. Among authors: yousef gm. Tumour Biol. 2016 Jan;37(1):437-46. doi: 10.1007/s13277-015-3802-7. Epub 2015 Jul 30. Tumour Biol. 2016. PMID: 26224476

2

Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.

Yousef GM, Diamandis EP. Yousef GM, et al. Tumour Biol. 2002 May-Jun;23(3):185-92. doi: 10.1159/000064027. Tumour Biol. 2002. PMID: 12218299 Review.

3

The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.

Yousef GM, Scorilas A, Nakamura T, Ellatif MA, Ponzone R, Biglia N, Maggiorotto F, Roagna R, Sismondi P, Diamandis EP. Yousef GM, et al. Breast Cancer Res Treat. 2003 Mar;78(2):149-58. doi: 10.1023/a:1022931403825. Breast Cancer Res Treat. 2003. PMID: 12725415

4

Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.

Borgoño CA, Fracchioli S, Yousef GM, Rigault de la Longrais IA, Luo LY, Soosaipillai A, Puopolo M, Grass L, Scorilas A, Diamandis EP, Katsaros D. Borgoño CA, et al. Among authors: yousef gm. Int J Cancer. 2003 Sep 10;106(4):605-610. doi: 10.1002/ijc.11296. Int J Cancer. 2003. PMID: 12845660

5

Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.

Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C, Rigault de la Longrais IA, Puopolo M, Massobrio M, Diamandis EP. Yousef GM, et al. J Clin Oncol. 2003 Aug 15;21(16):3119-26. doi: 10.1200/JCO.2003.09.111. J Clin Oncol. 2003. PMID: 12915603

6

Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.

Diamandis EP, Borgoño CA, Scorilas A, Yousef GM, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M. Diamandis EP, et al. Among authors: yousef gm. Tumour Biol. 2003 Nov-Dec;24(6):299-309. doi: 10.1159/000076462. Tumour Biol. 2003. PMID: 15004490

7

Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer.

Kurlender L, Yousef GM, Memari N, Robb JD, Michael IP, Borgoño C, Katsaros D, Stephan C, Jung K, Diamandis EP. Kurlender L, et al. Among authors: yousef gm. Tumour Biol. 2004 May-Jun;25(3):149-56. doi: 10.1159/000079147. Tumour Biol. 2004. PMID: 15361712

8

The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.

Yousef GM, White NM, Kurlender L, Michael I, Memari N, Robb JD, Katsaros D, Stephan C, Jung K, Diamandis EP. Yousef GM, et al. Tumour Biol. 2004 Sep-Dec;25(5-6):221-7. doi: 10.1159/000081384. Tumour Biol. 2004. PMID: 15627884

9

In silico analysis of the human kallikrein gene 6.

Yousef GM, Borgoño CA, White NM, Robb JD, Michael IP, Oikonomopoulou K, Khan S, Diamandis EP. Yousef GM, et al. Tumour Biol. 2004 Sep-Dec;25(5-6):282-9. doi: 10.1159/000081393. Tumour Biol. 2004. PMID: 15627893

10

Intron retention: a common splicing event within the human kallikrein gene family.

Michael IP, Kurlender L, Memari N, Yousef GM, Du D, Grass L, Stephan C, Jung K, Diamandis EP. Michael IP, et al. Among authors: yousef gm. Clin Chem. 2005 Mar;51(3):506-15. doi: 10.1373/clinchem.2004.042341. Epub 2005 Jan 13. Clin Chem. 2005. PMID: 15650036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters